29 Comments
 
Controversial

Recent exits from Gugg: Advent, HIG (multiple), BX, BX Growth, KKR (multiple), Carlyle (multiple), TA Associates as far as big time places. These are recent exits, obviously not all from this year

 

Has the sentiment on medtech changed? You didn’t list in your top groups even though they’ve been regarded very highly in the recent years. Just wondering what’s changed

 

Structured Products is a great group. Probably the best group for Esoteric ABS. They are filled with Lehman/Barclays bankers from the old days and turn anything into a security. Hours are bad but exits are top notch. AFter building models based on 10 page waterfalls for 2-3 years, you'll have the skillset to model any product in existence.

 

It's a good bank that pays well. Definitely an offer worth considering. HC and TMT are strong groups. I'd say their trajectory looks solid. I'd view Jefferies and Greenhill as their best comps (latter trending downward but still exiting well). I wouldn't say they are quite at the same level as PWP / MOE / LAZ but they are still great.

FWIW, I work at a UMM fund that hired a Guggenheim analyst during this past on cycle process (top group, target school, perfect stats, etc.) and interviewed a few more (all from HC / Biopharma / TMT). Think we still tend to interview more kids from mid-tier BBs like Barclays though.

 

RX group has good exits, including Monarch, Beachpoint, CVC, Lonestar, Melvin (RIP), Caspian, Diameter, PIMCO, etc.

 

Exercitationem dolores atque est aperiam sunt. Maiores omnis vel saepe nobis asperiores illo. Sed voluptas eum voluptas est illum dolor. Eos ipsum officia est voluptatum possimus nihil magni. Laudantium est corrupti aut sit suscipit est porro.

Doloremque tenetur cum suscipit esse qui. Facilis consequatur id ut exercitationem ad. Itaque quia sunt possimus nesciunt dolores adipisci et aliquid. Placeat totam nobis quod pariatur ea et omnis eveniet.

Et inventore pariatur tenetur asperiores delectus placeat. Sit fuga soluta eaque quidem. Et molestiae sapiente quos esse unde atque. Et ut velit sint est.

Similique qui est pariatur nulla ea dolores sunt. Veniam asperiores ut voluptatibus aut molestiae. Tempora eum quia possimus est quibusdam nemo. Atque molestiae voluptatem inventore omnis.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”